Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

986
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
986
Glucose Transporters01:27

Glucose Transporters

28.0K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.0K
Pleiotropy01:33

Pleiotropy

43.9K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.9K
Neural Regulation01:37

Neural Regulation

44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep brain stimulation of the anterior thalamic nucleus in Lennox-Gastaut syndrome with EEG changes during off-on stimulation.

Brain stimulation·2026
Same author

Cyclic alternating patterns of encephalopathy: implications for triphasic waves in noncomatose patients with metabolic-toxic encephalopathies.

Critical care (London, England)·2026
Same author

Beyond seizures: A multidimensional approach to non-seizure issues in Lennox-Gastaut syndrome. Insights from Italian experts.

Epilepsia open·2026
Same author

Centroparietal periodic sharp-wave discharges and biphasic complexes: Novel EEG biomarkers for early diagnosis of Rasmussen encephalitis.

Epilepsy & behavior reports·2026
Same author

An EEG-Based Edge-AI Framework for Alzheimer's and Creutzfeldt-Jakob Disease Classification.

Sensors (Basel, Switzerland)·2026
Same author

Epilepsia partialis continua as the presenting manifestation of Creutzfeldt-Jakob disease: A video-polygraphic clinical vignette.

Epileptic disorders : international epilepsy journal with videotape·2026

Related Experiment Video

Updated: Mar 15, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.6K

Unverricht-Lundborg disease.

Arielle Crespel1, Edoardo Ferlazzo2, Silvana Franceschetti3

  • 1Epilepsy Unit, Hôpital Gui-de-Chauliac, Research Unit 'Movement Disorders' (URMA), Department of Neurobiology, Institute of Functional Genomics, Montpellier, France.

Epileptic Disorders : International Epilepsy Journal with Videotape
|September 2, 2016
PubMed
Summary

Unverricht-Lundborg disease (ULD) is a progressive myoclonus epilepsy caused by mutations in the cystatin B (CSTB) gene. A mouse model revealed CSTB’s role in neuronal function, offering new therapeutic targets.

Keywords:
EPM1Unverricht-Lundborgprogressive myoclonus epilepsy

More Related Videos

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.5K

Related Experiment Videos

Last Updated: Mar 15, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.6K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Epilepsy Research

Background:

  • Unverricht-Lundborg disease (ULD) is a rare, progressive myoclonus epilepsy.
  • Current treatments for ULD are limited, necessitating a deeper understanding of its pathophysiology.
  • Genetic mutations, particularly in the cystatin B (CSTB) gene, are implicated in ULD.

Purpose of the Study:

  • To review current knowledge on ULD clinical presentation and therapies.
  • To describe the identification of disease-causing mutations in the CSTB gene.
  • To elucidate the mechanisms underlying ULD pathophysiology using a novel mouse model.

Main Methods:

  • Literature review of ULD clinical aspects and therapeutics.
  • Identification and characterization of mutations in the human CSTB gene.
  • Generation and analysis of a Cstb-deficient mouse model exhibiting ULD features.

Main Results:

  • The CSTB gene was identified as a key genetic factor in ULD.
  • The Cstb-deficient mouse model successfully recapitulated ULD phenotypes: myoclonic seizures, ataxia, and neuronal loss.
  • Studies revealed Cstb's involvement in protease inhibition, glial activation, oxidative stress, neurotransmission, and neuronal excitability.

Conclusions:

  • CSTB mutations are central to Unverricht-Lundborg disease pathogenesis.
  • The Cstb-deficient mouse model is a valuable tool for studying ULD mechanisms.
  • Understanding Cstb's diverse biological roles provides potential pathways for developing improved ULD therapies.